Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Understanding what a beginner investment portfolio looks like is crucial for new investors. Learn the basics to kickstart your investment journey.
27,003 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A tariff reversal can trigger a short-lived stock market surge, but gains often fade as details unfold. This guide ex...
A 25-year-old claims financial independence with $500k in index funds and 11 rental units, but experts say real indep...
SPHD has sustained monthly distributions since its inception by tapping a mix of high-yield, low-volatility holdings....
A powerful wave of industry consolidation in 2026 is reshaping energy markets, elevating takeover risk for select sma...
Micron Technology races higher on AI memory demand and supply tightness. This piece outlines why investors may consid...
Investors chase $100,000 a year in dividend income, but the required capital hinges on yield and payout durability in...
In a choppy market shaped by inflation and global tensions, three stocks stand out for potential to beat market retur...
AGNT, Inc. has completed its corporate transformation, changing its name and moving its domicile to Texas. The move i...
European stocks climb as the Vanguard FTSE Europe ETF approaches fresh highs. Investors debate whether this marks a d...
Europe’s top AI startups are accelerating moves to the U.S. amid a flood of AI-focused funding. The trend is reshapin...
As markets enter the midyear phase of 2026, three proven compounders highlight why patient investing still works. App...